Complement activation in Klebsiella pneumoniae

Reviews and Research in Medical Microbiology

Volumn 9, Issue 2, 1998, Pages 69-77

  Benedí, Vicente J ^a,e   Vivanco, Fernando ^b,c   Tomás, Juan M ^d  

^a INSTITUTO MEDITERRÁNEO DE ESTUDIOS AVANZADOS   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Capsule; Complement; Klebsiella pneumoniae; Lipopolysaccharide; Outer membrane; Porins

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT; COMPLEMENT COMPONENT C3B; LIPOPOLYSACCHARIDE; O ANTIGEN; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CYTOLYSIS; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

EID: 0031952726     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199804000-00001     Document Type: Article

References (38)

1. Figueroa JE, Densen P. Infectious diseases associated with Complement deficiencies. Clin Microbiol Rev 1991; 4: 359-395.
2. Cooper N. Complement evasion strategies of microorganisms. Immunol Today 1991; 12: 327-331.
3. Joiner KA. Complement evasion by bacteria and parasites. Annu Rev Microbiol 1988; 42: 201-230.
4. Law A, Reid K. Complement. Oxford: IRL Press, 1996.
5. Lachmann P. Current topics in Complement research. Res Immunol 1996; 147: 65-124.
6. Lachmann P. The biology of the Complement system. Springer Semin Immunopathol 1994; 15: 303-431.
7. Reid K, Turner M. Mammalian lectins in activation and clearance mechanism involving the Complement system. Springer Semin Immunopathol 1996; 15: 307-325.
8. Turner M. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
9. Turner M. The lectin pathway of Complement activation. Res Immunol 1996; 147: 110-115.
10. Morgan B, Men S. Membrane proteins that protect against Complement lysis. Springer Semin Immunopathol 1994; 15: 369-396.
11. Esser A. The membrane attack complex of Complement. Assembly, structure and cytotoxic activity. Toxicology 1994; 87: 229-247.
12. Thiel S, Vorup-Jensen T, Stover C et al. A second serin protease associated with mannan-binding lectin that activates Complement. Nature 1997; 386: 506-510.
13. Liszewski M, Fames T, Lublin D, Rouney J, Atkinson J. Control of the Complement system. Adv Immunol 1996; 61: 201-283.
14. Moffit M, Frank M. Complement resistance in microbes. Springer Semin Immunopathol 1994; 15: 327-344.
15. Reeves P. Role of O-antigen variation in the immune response. Trends Microbiol 1995; 3: 381-386.
16. Fishelson Z. Complement-related proteins in pathogenic organisms. Springer Semin Immunopathol 1994; 15: 345-368.
17. Merino S, Camprubí S, Albertí S, Benedí VJ, Tomás JM. Mechanisms of Klebsiella pneumoniae resistance to Complement-mediated killing. Infect Immun 1992; 60: 2529-2535.
18. Tomás JT, Camprubí S, Merino S, Davey MR, Williams P. Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. Infect Immun 1991; 59: 2006-2011.
19. Salo R, Domenico P, Tomás JM et al. Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components. Infection 1995; 23: 371-377.
20. Pluschke G, Mayden J, Achtman M, Levine RP. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to Complement-mediated killing. Infect Immun 1983; 42: 907-913.
21. Podschun R, Sievers D, Fischer A, Ullmann U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 1993; 168: 1415-1421.
22. Cryz SJ, Mortimer PM, Mansfield V, Germanier R. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 1986; 23: 687-690.
23. Ørskov I, Ørskov F. Serotyping of Klebsiella. In: Bergan T, ed. Methods in microbiology, vol. 14, 143-164. New York: Academic Press, 1984.
24. Benedí VJ, Jofre J, Tomás JM. Klebsiella pneumoniae C3 lipopolysaccharide mutants obtained by resistance to bacteriophage FC3-9. Ann Inst Pasteur/Microbiol 1986; 137 B: 29-36.
25. Tomás JM, Benedí VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54: 85-89.
26. Ciurana B, Tomás JM. Role of lipopolysaccharide and Complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun 1987; 55: 2741-2746.
27. Yokochi T, Inoue Y, Kimura Y, Kato N. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with Complement and its relation to adjuvant action. J Immunol 1990; 144: 3106-3110.
28. Albertí S, Alvarez D, Merino S et al. Analysis of Complement C3 deposition and degradation on Klebsiella pneumoniae. Infect Immun 1996; 64: 4726-4732.
29. Jiang GZ, Sugiyama T, Kato Y, Koide N, Yokochi T. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide as the O-specific polysaccharide and its relation to Complement activation. Infect Immun 1995; 63: 2537-2540.
30. Albertí S, Marqués G, Camprubí S et al. C1q binding and activation of the Complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 1993; 61: 852-860.
31. Albertí S, Rodríguez-Quiñones F, Schirmer T et al. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional structure, and Complement binding. Infect Immun 1995; 63: 903-910.
32. Galanos C, Rietschel ET, Lüderitz O, Westphal O. Interaction of lipopolysaccharides and Lipid A with Complement. Eur J Biochem 1971; 19: 143-152.
33. Albertí S, Marqués G, Hernández-Allés S et al. Interaction between Complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun 1996; 64: 4719-4725.
34. Jeanteur D, Lakey JH, Pattus F. The bacterial porin superfamily: sequence alignment and structure prediction. Mol Microbiol 1991; 5: 2153-2164.
35. Latsch M, Mollerfeld J, Ringsdorf H, Loos M. Studies on the interaction of C1q, a subcomponent of the first component of Complement, with porins from Salmonella minnesota incorporated into artificial membranes. FEBS Lett 1990; 276: 201-204.
36. Galdiero F, Tufano MA, Sommese L, Folgore A, Tedesco F. Activation of Complement system by porins extracted from Salmonella typhimurium. Infect Immun 1984; 46: 559-563.
37. Cowan SW, Schirmer T, Rummel G et al. Crystal structures explain functional properties of two E. coli porins. Nature 1992; 358: 727-733.
38. Duncan AR, Winter G. The binding site for C1q on IgG. Nature 1988; 332: 738-740.